Compare Cara Therapeutics vs Christaens International
Customers evaluate the quality of Cara Therapeutics's products using the following success metrics.
Overview
Cara Therapeutics is 20 yrs old and is based in United States.
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).
Christaens International is based in Switzerland
Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory diseases, inflammation diseases, pain, osteoporosis and tissue management. nnIts R&D is built to be open for partnerships also beyond its core areas in inflammatory, respiratory diseases and pain as in-licensing is a cornerstone in the company's growth strategy.
Demo Video
Leadership
Derek Chalmers (Chief Executive Officer, President)
Investors
Ascent Biomedical Ventures, Mitsubishi Corporation Life Sciences Ventures
Alta Berkeley
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cara Therapeutics has not claimed their profile.
Work for Cara Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cara Therapeutics?
Claim your profile now.
Information not available because Christaens International has not claimed their profile.
Work for Christaens International? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Christaens International?
Claim your profile now.